These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study. Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Drug Alcohol Depend; 2019 Jan 01; 194():527-532. PubMed ID: 30551090 [Abstract] [Full Text] [Related]
5. A qualitative assessment of key considerations for drug checking service implementation. Grace Rose C, Pickard AS, Kulbokas V, Hoferka S, Friedman K, Epstein J, Lee TA. Harm Reduct J; 2023 Oct 17; 20(1):151. PubMed ID: 37848875 [Abstract] [Full Text] [Related]
6. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply. Shin SS, LaForge K, Stack E, Pope J, Leichtling G, Larsen JE, Leahy JM, Seaman A, Hoover D, Chisholm L, Blazes C, Baker R, Byers M, Branson K, Korthuis PT. Harm Reduct J; 2022 Jul 11; 19(1):76. PubMed ID: 35818072 [Abstract] [Full Text] [Related]
7. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. Reed MK, Guth A, Salcedo VJ, Hom JK, Rising KL. Int J Drug Policy; 2022 May 11; 103():103643. PubMed ID: 35255392 [Abstract] [Full Text] [Related]
15. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada. Klaire S, Janssen RM, Olson K, Bridgeman J, Korol EE, Chu T, Ghafari C, Sabeti S, Buxton JA, Lysyshyn M. Int J Drug Policy; 2022 Aug 11; 106():103741. PubMed ID: 35671687 [Abstract] [Full Text] [Related]
16. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island. Collins AB, Kaplowitz E, Bastani P, McKee H, Whitaker D, Hallowell BD, McKenzie M. Subst Use Misuse; 2024 Aug 11; 59(5):673-679. PubMed ID: 38124349 [Abstract] [Full Text] [Related]
17. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users. Swartz JA, Lieberman M, Jimenez AD, Mackesy-Amiti ME, Whitehead HD, Hayes KL, Taylor L, Prete E. Harm Reduct J; 2023 Jul 07; 20(1):87. PubMed ID: 37420196 [Abstract] [Full Text] [Related]
18. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives. Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, Arnold EA. Harm Reduct J; 2024 May 11; 21(1):92. PubMed ID: 38734643 [Abstract] [Full Text] [Related]
19. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont. Erath TG, LaCroix R, O'Keefe E, Higgins ST, Rawson RA. Harm Reduct J; 2024 Apr 05; 21(1):76. PubMed ID: 38580997 [Abstract] [Full Text] [Related]
20. Costing analysis of a point-of-care drug checking program in Rhode Island. Cepeda JA, Thompson E, Ujeneza M, Tardif J, Walsh T, Morales A, Rosen JG, Green TC, Park JN. Drug Alcohol Depend; 2023 Dec 01; 253():111028. PubMed ID: 38000322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]